A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)
Condition(s):Geographic AtrophyLast Updated:January 20, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Geographic AtrophyLast Updated:January 20, 2014Terminated
Condition(s):Atrophic Anterior Maxillary RidgesLast Updated:January 26, 2021Unknown status
Condition(s):Type 2 Spinal Muscular Atrophy; Type 3 Spinal Muscular AtrophyLast Updated:July 19, 2018Completed
Condition(s):Type 2 Spinal Muscular AtrophyLast Updated:February 22, 2024Active, not recruiting
Condition(s):Geographic AtrophyLast Updated:June 18, 2023Completed
Condition(s):Geographic AtrophyLast Updated:July 5, 2022Active, not recruiting
Condition(s):Age-Related Macular Degeneration; Geographic Atrophy; Reticular PseudodrusenLast Updated:February 17, 2020Completed
Condition(s):Vaginal AtrophyLast Updated:December 22, 2021Completed
Condition(s):Geographic AtrophyLast Updated:October 1, 2020Completed
Condition(s):Spinal Muscular AtrophyLast Updated:December 12, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.